Skip to main content
PMC home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1987 Sep;63(743):731–733. doi: 10.1136/pgmj.63.743.731

The pathogenesis and treatment of Graves' ophthalmopathy.

I R Jones 1
PMCID: PMC2428550  PMID: 3444795

Full text

PDF
731

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Atkinson S., Holcombe M., Kendall-Taylor P. Ophthalmopathic immunoglobulin in patients with Graves' ophthalmopathy. Lancet. 1984 Aug 18;2(8399):374–376. doi: 10.1016/s0140-6736(84)90543-9. [DOI] [PubMed] [Google Scholar]
  2. BLOMFIELD G. W., ECKERT H., FISHER M., MILLER H., MUNRO D. S., WILSON G. M. Treatment of thyrotoxicosis with 131 I; a review of 500 cases. Br Med J. 1959 Jan 10;1(5114):63–74. doi: 10.1136/bmj.1.5114.63. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Blau H. M., Kaplan I., Tao T. W., Kriss J. P. Thyroglobulin-independent, cell-mediated cytotoxicity of human eye muscle cells in tissue culture by lymphocytes of a patient with Graves' ophthalmopathy. Life Sci. 1983 Jan 3;32(1-2):45–53. doi: 10.1016/0024-3205(83)90172-8. [DOI] [PubMed] [Google Scholar]
  4. Brohee D., Delespesse G., Debisschop M. J., Bonnyns M. Circulating immune complexes in various thyroid diseases. Clin Exp Immunol. 1979 Jun;36(3):379–383. [PMC free article] [PubMed] [Google Scholar]
  5. Farid N. R., Sampson L., Noel E. P., Barnard J. M., Mandeville R., Larsen B., Marshall W. H., Carter N. D. A study of human leukocyte D locus related antigens in Graves' disease. J Clin Invest. 1979 Jan;63(1):108–113. doi: 10.1172/JCI109263. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Feldt-Rasmussen U., Kemp A., Bech K., Madsen S. N., Date J. Serum thyroglobulin, its autoantibody and thyroid stimulating antibodies in the endocrine exophthalmos. Acta Endocrinol (Copenh) 1981 Feb;96(2):192–198. doi: 10.1530/acta.0.0960192. [DOI] [PubMed] [Google Scholar]
  7. Gorman C. A. Temporal relationship between onset of Graves' ophthalmopathy and diagnosis of thyrotoxicosis. Mayo Clin Proc. 1983 Aug;58(8):515–519. [PubMed] [Google Scholar]
  8. Gwinup G., Elias A. N., Ascher M. S. Effect on exophthalmos of various methods of treatment of Graves' disease. JAMA. 1982 Apr 16;247(15):2135–2138. [PubMed] [Google Scholar]
  9. Kelly W., Longson D., Smithard D., Fawcitt R., Wensley R., Noble J., Keeley J. An evaluation of plasma exchange for Graves' ophthalmopathy. Clin Endocrinol (Oxf) 1983 May;18(5):485–493. doi: 10.1111/j.1365-2265.1983.tb02878.x. [DOI] [PubMed] [Google Scholar]
  10. Konishi J., Herman M. M., Kriss J. P. Binding of thyroglobulin and thyroglobulin-antithyroglobulin immune complex to extraocular muscle membrane. Endocrinology. 1974 Aug;95(2):434–446. doi: 10.1210/endo-95-2-434. [DOI] [PubMed] [Google Scholar]
  11. Kriss J. P., Konishi J., Herman M. Studies on the pathogenesis of Graves' ophthalmopathy (with some related observations regarding therapy). Recent Prog Horm Res. 1975;31:533–566. doi: 10.1016/b978-0-12-571131-9.50018-9. [DOI] [PubMed] [Google Scholar]
  12. Kriss J. P., Pleshakov V., Rosenblum A. L., Holderness M., Sharp G., Utiger R. Studies on the pathogenesis of the ophthalmopathy of Graves' disease. J Clin Endocrinol Metab. 1967 Apr;27(4):582–593. doi: 10.1210/jcem-27-4-582. [DOI] [PubMed] [Google Scholar]
  13. Mashieu P., Winand R. Demonstration of delayed hypersensitivity to retrobulbar and thyroid tissues in human exophthalmos. J Clin Endocrinol Metab. 1972 Jun;34(6):1090–1092. doi: 10.1210/jcem-34-6-1090. [DOI] [PubMed] [Google Scholar]
  14. McKenzie J. M., McCullagh E. P. Observations against a causal relationship between the long-acting thyroid stimulator and ophthalmopathy in Graves' disease. J Clin Endocrinol Metab. 1968 Aug;28(8):1177–1182. doi: 10.1210/jcem-28-8-1177. [DOI] [PubMed] [Google Scholar]
  15. Mullin B. R., Levinson R. E., Friedman A., Henson D. E., Winand R. J., Kohn L. D. Delayed hypersensitivity in Graves' disease and exophthalmos: identification of thyroglobulin in normal human orbital muscle. Endocrinology. 1977 Feb;100(2):351–366. doi: 10.1210/endo-100-2-351. [DOI] [PubMed] [Google Scholar]
  16. Munro R. E., Lamki L., Row V. V., Volpé R. Cell-mediated immunity in the exophthalmos of Graves' disease as demonstrated by the migration inhibition factor (MIF) test. J Clin Endocrinol Metab. 1973 Aug;37(2):286–292. doi: 10.1210/jcem-37-2-286. [DOI] [PubMed] [Google Scholar]
  17. Shillinglaw J., Utiger R. D. Failure of retro-orbital tissue to neutralize the biological activity of the long-acting thyroid stimulator. J Clin Endocrinol Metab. 1968 Jul;28(7):1069–1070. doi: 10.1210/jcem-28-7-1069. [DOI] [PubMed] [Google Scholar]
  18. Sisson J. C., Kothary P., Kirchick H. The effects of lymphocytes, sera, and long-acting thyroid stimulator from patients with Graves' disease on retrobulbar fibroblasts. J Clin Endocrinol Metab. 1973 Jul;37(1):17–24. doi: 10.1210/jcem-37-1-17. [DOI] [PubMed] [Google Scholar]
  19. Solomon D. H., Chopra I. J., Chopra U., Smith F. J. Identification of subgroups of euthyroid graves's ophthalmopathy. N Engl J Med. 1977 Jan 27;296(4):181–186. doi: 10.1056/NEJM197701272960401. [DOI] [PubMed] [Google Scholar]
  20. Takeda Y., Kriss J. P. Radiometric measurement of thyroglobulin-antithyroglobulin immune complex in human serum. J Clin Endocrinol Metab. 1977 Jan;44(1):46–55. doi: 10.1210/jcem-44-1-46. [DOI] [PubMed] [Google Scholar]
  21. Teoh R., Woo J. Combined irradiation and low-dose cyclophosphamide in the treatment of Graves' ophthalmopathy. Postgrad Med J. 1987 Sep;63(743):777–779. doi: 10.1136/pgmj.63.743.777. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Tunbridge W. M., Evered D. C., Hall R., Appleton D., Brewis M., Clark F., Evans J. G., Young E., Bird T., Smith P. A. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) 1977 Dec;7(6):481–493. doi: 10.1111/j.1365-2265.1977.tb01340.x. [DOI] [PubMed] [Google Scholar]
  23. Weetman A. P., McGregor A. M., Ludgate M., Beck L., Mills P. V., Lazarus J. H., Hall R. Cyclosporin improves Graves' ophthalmopathy. Lancet. 1983 Aug 27;2(8348):486–489. doi: 10.1016/s0140-6736(83)90514-7. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES